华康生物医学(08622) - 2020 Q3 - 季度财报

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 2020 Third Quarterly Report 第三季業績報告 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than ...